Update of pneumonia in the elderly;Actualización de la neumonía en el anciano

Revista Espanola de Geriatria y Gerontologia

Volumn 48, Issue 2, 2013, Pages 72-78

  Torres, Olga H ^a   Gil, Eva ^a   Pacho, Cristina ^a   Ruiz, Domingo ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Aspiration pneumonia; Community acquired pneumonia; Health care associated pneumonia; Pneumonia in the elderly; Treatment of pneumonia

Indexed keywords

ANTIBIOTIC AGENT; STEROID;

ANTIBIOTIC THERAPY; ASPIRATION PNEUMONIA; DYSPHAGIA; ELDERLY CARE; HUMAN; INCIDENCE; MOBILIZATION; MORBIDITY; MORTALITY; MOUTH HYGIENE; PNEUMONIA; RISK ASSESSMENT; SHORT SURVEY; TREATMENT DURATION;

EID: 84875545049     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2012.06.001     Document Type: Short Survey

References (66)

1. Osler W. The Principles and Practice of Medicine 1898, D Appleton & Co, New York, NY, 109-112.
2. Mayaud C. Pneumonia is the leading cause of death of infectious origin. Rev Prat 2011, 61:1061-1063.
3. Ochoa-Gondar O. Epidemiología de la neumonía adquirida en la comunidad en el anciano [tesis doctoral] 2010 [consultado 20 May 2012]. Disponible en: http://www.tesisenred.net/bitstream/handle/10803/8745/tesis.pdf%3Fsequence=1.
4. Instituto Nacional de Estadística. Encuesta de morbilidad hospitalaria 2009. En: INEbase. Salud [consultado 3 Mar 2012]. Disponible en: http://www.ine.es/jaxi/menu.do%3Ftype=pcaxis%26path=%2Ft15/p414%26file=inebase%26L=0.
5. Sousa D., Justo I., Domínguez A., Manzur A., Izquierdo C., Ruiz L., et al. Community-acquired pneumonia in immunocompromised older patients: incidente, causative organisms and outcome. Clin Microbiol Infect 2012 Jan 10, [Epub ahead of print]. 10.1111/j.1469-0691.2012.03765.x.
6. Liñares J., Ardanuy C., Pallares R., Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010, 16:402-410.
7. Thiem U., Heppner H.J., Pientka L. Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging 2011, 28:519-537.
8. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic Society Infectious; Diseases Society of America,.
9. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
10. Carratalà J., Mykietiuk A., Fernández-Sabé N., Suárez C., Dorca J., Verdaguer R., et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007, 167:1393-1399.
11. Ewig S., Welte T., Chastre J., Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010, 10:279-287.
12. Shariatzadeh M.R., Huang J.Q., Marrie T.J. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006, 54:296-302.
13. Van der Maarel-Wierink C.D., Vanobbergen J.N.O., Bronkhorst E.M., Schols J.M.G.A., de Baat C. Meta-analysis of dysphagia and aspiration pneumonia in frail elders. J Dent Res 2011, 90:1398-1404.
14. Turley R., Cohen S. Impact of voice and swallowing problems in the elderly. Otolaryngol Head Neck Surg 2009, 140:33-36.
15. Lin L.C., Wu S.C., Chen H.S., Wang T.G., Chen M.Y. Prevalence of impaired swallowing in institutionalised older people in Taiwan. J Am Geriatr Soc 2002, 50:1118-1123.
16. Van der Maarel-Wierink C.D., Vanobbergen J.N., Bronkhorst E.M., Schols J.M., de Baat C. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc 2011, 12:344-354.
17. Cabré M., Serra-Prat M., Palomera E., Almirall J., Pallarés R., Clavé P. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. AgeAgeing 2010, 39:39-45.
18. Wilkinson A.H., Burns S.L., Witham M.D. Aspiration in older patients without stroke: a systematic review of bedside diagnostic tests and predictors of pneumonia. Eur Geriatr Med 2012, 3:145-152.
19. Yip K.H., Smales R.J. Implications of oral biofilms in medically at risk persons. J Biomed Res 2012, 26:1-7.
20. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
21. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
22. Bauer T.T., Ewig S., Marre R., Suttorp N., Welte T. CRB-65 predicts death from community-acquired pneumonia 2006, 260:93-101. CAPNETZ Study Group.
23. Loke Y.K., Kwok C.S., Niruban A., Myint P.K. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010, 65:884-890.
24. Chalmers J.D., Singanayagam A., Akram A.R., Mandal P., Short P.M., Choudhury G., et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia, Systematic review and meta-analysis. Thorax 2010, 65:878-883.
25. Majumdar S.R., Eurich D.T., Gamble J.M., Senthilselvan A., Marrie T.J. Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clin Infect Dis 2011, 52:325-331.
26. Torres O.H., Muñoz J., Ruiz D., Ris J., Gich I., Coma E., et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004, 52:1603-1609.
27. Fang W.F., Yang K.Y., Wu C.L., Yu C.J., Chen C.W., Tu C.Y., et al. Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia. Crit Care 2011, 15:R32.
28. Basi S.K., Marrie T.J., Huang J.Q., Majumdar S.R. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004, 117:305-311.
29. Esayag Y., Nikitin I., Bar-Ziv J., Cytter R., Hadas-Halpern I., Zalut T., et al. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med 2010, 123:88.e1-88.e5.
30. El Solh A.A., Aquilina A.T., Gunen H., Ramadan F. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc 2004, 52:224-229.
31. Almirall J., Bolíbar I., Toran P., Pera G., Boquet X., Balanzó X., et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004, 125:1335-1342. Community-Acquired Pneumonia Maresme Study Group.
32. Stucker F., Herrmann F., Graf J.D., Michel J.P., Krause K.H., Gavazzi G. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005, 53:1392-1395.
33. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 2007, 44:S27-S72. Infectious Diseases Society of America; American Thoracic Society.
34. Shekelle P.G., MacLean C.H., Morton S.C., Wenger N.S. Acove quality indicators. Ann Intern Med 2001, 135:653-667.
35. Corbo J., Friedman B., Bijur P., Gallagher E.J. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J 2004, 21:446-448.
36. Sordé R., Falcó V., Lowak M., Domingo E., Ferrer A., Burgos J., et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 2011, 171:166-172.
37. Rodríguez C, Alfageme I. Guía de buena práctica clínica en Geriatría: Neumonías, 2006 [consultado 20 May 2012]. Disponible en: http://www.segg.es/descarga.asp?tipo=1&pag=1.
38. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2009, 64(Suppl 3):S1-S55. Pneumonia Guidelines Committee of the BTS Standards of Care Committee.
39. Fishbane S., Niederman M.S., Daly C., Magin A., Kawabata M., de Corla-Souza A., et al. The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Arch Intern Med 2007, 167:1664-1669.
40. Pachón J., Falguera M., Gudiol F., Sabrià M., álvarez-Lerma F., Cordero E. Protocolos de la SEIMC Infecciones en el tracto respiratorio inferior [consultado 20 May 2012] 2012, Disponible en: http://www.seimc.org/documentos/protocolos/clinicos/I.pdf.
41. Menendez R., Torres A., Aspa J., Capelastegui A., Prat C., Rodri{dotless}guez de Castro F. neumonía adquirida en la comunidad. Nueva normativa de la sociedad española de neumología y cirugía torácica (SEPAR). Arch Bronconeumol 2010, 46:543-558.
42. Frei C.R., Labreche M.J., Attridge R.T. Fluoroquinolones in community-acquired pneumonia: Guide to selection and appropriate use. Drugs 2011, 71:757-770.
43. Wunderink R.G., Niederman M.S., Kollef M.H., Shorr A.F., Kunkel M.J., Baruch A., et al. Linezolid in methicillin-resistant staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012, 54:621-629.
44. Florescu D.F., Qiu F., McCartan M.A., Mindru C., Fey P.D., Kalil A.C. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression. Clin Infect Dis 2012, 54:670-680.
45. Mills G.D., Oehley M.R., Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005, 330:456.
46. Robenshtok E., Shefet D., Gafter-Gvili A., Paul M., Vidal L., Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2008, 1:CD004418.
47. Gleason P.P., Meehan T.P., Fine J.M., Galusha D.H., Fine M.J. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with penumonia. Arch Intern Med 1999, 159:2562.
48. Waterer G.W., Somes G.W., Wunderink R.G. Monotherapy may be sub-optimal for severe bacteremic pneumococcal pneumoniae. Arch Intern Med 2001, 161:1837-1842.
49. Mufson M.A., Stanek R.J. Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997. Am J Med 1999, 107:34S-43S.
50. Paul M., Benuri-Silbiger I., Soares-Weiser K., Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004, 328:668.
51. Oosterheert J.J., Bonten M.J.M., Schneider M.M.E., Buskens E., Lammers J.W.J., Hustinx W.M.N. Effectiveness of early switch fromintravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006, 333:1193-1197.
52. Pugh R., Grant C., Cooke R.P., Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2011, CD007577.
53. Dimopoulos G., Matthaiou D.K., Karageorgopoulos D.E., Grammatikos A.P., Athanassa Z., Falagas M.E., et al. Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs 2008, 68:1841-1854.
54. Li J.Z., Winston L.G., Moore D.H., Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med 2007, 120:783-790.
55. Chen Y., Li K., Pu H., Wu T. Corticosteroides para la neumonía. Cochrane Database of Systematic Reviews 2011.
56. Meijvis S.C., Hardeman H., Remmelts H.H., Heijligenberg R., Rijkers G.T., van Velzen-Blad H., et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:2023-2030.
57. Mikami K., Suzuki M., Kitagawa H., Kawakami M., Hirota N., Yamaguchi H., et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007, 185:249-255.
58. Mundy L.M., Leet T.L., Darst K., Schnitzler M.A., Dunagan W.C. Early mobilization of patients hospitalized with community-acquired pneumonia. Chest 2003, 124:883-889.
59. Corrales-Medina V., Musher D.M., Wells G.A., Chirinos J.A., Chen L., Fine M.J. Cardiac Complications in patients with community-acquired pneumonia: incidente, timing, risk factors, and association with short-term mortality. Circulation 2012, 125:773-781.
60. Ebihara S., Ebihara T., Yamasaki M., Kohzuki M. Stimulating oral and nasal chemoreceptors for preventing aspiration pneumonia in the elderly. Yakugaku Zasshi 2011, 131:1677-1681.
61. Pace C.C., McCullough G.H. The association between oral microorgansims and aspiration pneumonia in the institutionalized elderly: review and recommendations. Dysphagia 2010, 25:307-322.
62. Fedson D.S., Nicolas-Spony L., Klemets P., van der Linden M., Marques A., Salleras L., et al. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines 2011, 10:1143-1167.
63. Michel J.P., Chidiac C., Grubeck-Loebenstein B., Johnson R.W., Lambert P.H., Maggi S., et al. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res 2009, 12:127-135.
64. Guía de práctica clínica sobre la atención integral a las personas con enfermedad de Alzheimer y otras demencias. Generalitat de Catalunya. Ministerio de Sanidad, Política social e Igualdad. Disponible en: [consultado 20 May 2012]. http://www.gencat.cat/salut/depsan/units/aatrm/pdf/gpc_alzheimer_demencias_pcsns_aiaqs_2011vc.pdf.
65. Givens J.L., Jones R.N., Shaffer M.L., Kiely D.K., Mitchell S.L. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010, 170:1102-1107.
66. Van der Steen J.T., Ooms M.E., van der W.G., Ribbe M.W. Withholding or starting antibiotic treatment in patients with dementia and pneumonia: prediction of mortality with physicians' judgment of illness severity and with specific prognostic models. Med Decis Making 2005, 25:210-221.